Systematic Review of the Safety and Efficacy of Palivizumab among Infants and Young Children with Cystic Fibrosis.

about

Alternative Viewpoint: Efficacy and Effectiveness of Respiratory Syncytial Virus Immunoprophylaxis in Children with Cystic Fibrosis - An Unsolved Question with More to Be Asked.Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children.

P2860

Q41929955-C1699C0B-EB11-4875-AE74-21DF947C6481 Q50262223-8E2C8555-8D9F-4B1D-B5B2-BE24B9981B8B

P2860

Systematic Review of the Safety and Efficacy of Palivizumab among Infants and Young Children with Cystic Fibrosis.

Item

http://www.wikidata.org/entity/Q38830272

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Systematic Review of the Safet ...... Children with Cystic Fibrosis.

@en

type

Item

label

Systematic Review of the Safet ...... Children with Cystic Fibrosis.

@en

prefLabel

Systematic Review of the Safet ...... Children with Cystic Fibrosis.

@en

P1476

Systematic Review of the Safet ...... Children with Cystic Fibrosis

@en

P2093

Kok Pim Kua

http://www.w3.org/2001/XMLSchema#string

Shaun Wen Huey Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

Respiratory syncytial virus infection.

Effectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season. The Palivizumab Outcomes Study Group.

Safety and Effectiveness of Palivizumab in Children at High Risk of Serious Disease Due to Respiratory Syncytial Virus Infection: A Systematic Review.

Impact of respiratory viral infections on cystic fibrosis.

Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations

Relative impact of influenza and respiratory syncytial virus in young children

Anti-RSV prophylaxis efficacy for infants and young children with cystic fibrosis in Ireland

P304

755-769

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PHAR.1936

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shaun Lee

Kok Pim Kua

P577

2017-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28423192

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

Systematic Review of the Safety and Efficacy of Palivizumab among Infants and Young Children with Cystic Fibrosis.

about

P2860

P2860

Systematic Review of the Safety and Efficacy of Palivizumab among Infants and Young Children with Cystic Fibrosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921